Sermorelin Complete Drug-Drug Interaction Profile
HealthRX.com
Sermorelin interactions are largely unstudied
Key numbers
- 30 micrograms/kgSubcutaneous sermorelin dose given at bedtime to children with growth hormone deficiency in the pediatric trial, for up to a yearSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 4.1 cm/yrHeight velocity at baseline in prepubertal children with growth hormone deficiency, before sermorelin treatmentSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 8.0 cm/yrHeight velocity at 6 months of sermorelin treatment in the pediatric trial, up from 4.1 cm/yr at baselineSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
At a glance
- Studied combination / Intravenous sermorelin with arginine for diagnostic testing in adults [1]
- FDA status / No approved sermorelin product; Geref approvals withdrawn June 18, 2009 [2]
- What sermorelin does / Acts on the pituitary GHRH receptor to release the body's own growth hormone [1]
- Pediatric trial / 110 children enrolled, 86 evaluable, 30 mcg/kg nightly for up to 1 year; fasting glucose unchanged [3]
- Products sold today / Compounded and not FDA-approved [4]
- Bulk-substance safety list / Sermorelin is not listed among bulk substances FDA flags as significant safety risks [5]
Is there a current interaction list for sermorelin?
There is no current FDA label for sermorelin, because no sermorelin product is approved. Geref came under two FDA applications, NDA 019863 for the 0.05 mg ampule and NDA 020443 for the 0.5 mg and 1 mg vials [2]. The manufacturer discontinued both in 2008 and asked FDA to withdraw the applications, which FDA did effective June 18, 2009 [2]. In March 2013 FDA determined that Geref was not withdrawn from sale for reasons of safety or effectiveness [2].
The one studied combination: sermorelin plus arginine
The sermorelin review reports adult data indicating that intravenous sermorelin combined with arginine is a more specific diagnostic test [1]. It also notes that normal growth hormone responses to intravenous sermorelin cannot exclude growth hormone deficiency due to a hypothalamic deficit, and that subnormal responses to other provocative tests are needed to confirm disease in those patients [1]. This finding is about diagnosis, not about treatment or safety of the combination.
What the human trials recorded
In an open-label, multicenter study, 110 previously untreated prepubertal children with growth hormone deficiency (86 evaluable) were given 30 micrograms/kg subcutaneously at bedtime for up to a year [3]. Height velocity rose from 4.1 cm/yr at baseline to 8.0 cm/yr at 6 months and 7.2 cm/yr at 12 months [3]. The trial reported no adverse changes in general biochemical or hormonal analyses, no change in fasting glucose, no excessive rise in IGF-I, and good overall tolerability [3]. These were safety measurements in one treated group, not tests of drug combinations.
A short physiology study gave 10 healthy old men (mean age 68) 0.5 mg and 1 mg subcutaneously twice daily for 14 days each. At the high dose, 24-hour growth hormone and IGF-I rose to levels not significantly different from 9 young men (mean age 26) [6]. It was not a clinical-benefit trial.
What about other medicines?
Sermorelin acts on the pituitary GHRH receptor to make the body release its own growth hormone, and it is not growth hormone itself [1]. How it behaves alongside growth hormone, somatostatin analogues such as octreotide, glucocorticoids, sex hormones, opioids or diabetes drugs is not established by the arginine diagnostic finding or by the trials above.
What people on Reddit report
Reddit users describing sermorelin taken alongside tirzepatide or during hormone treatment. These are personal reports, not clinical data, and they do not show how the drugs interact.
I stopped taking it because it just make me hungry even taking with tirzRead the source discussion
I actually started Sermorelin last week and am still on tirz! I'm curious to see how they work together.Read the source discussion
My hormones were apparently all wonky, so I got off the Sermorelin and had to get on an E patch and get my testosterone lined out- now back on week two of Sermorelin- finally 🥴 I hate being a woman, sometimes.Read the source discussion
Questions worth asking
The products sold today
With Geref gone, sermorelin products in the US are compounded, and compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before they are marketed [4]. Sermorelin is not on FDA's list of bulk substances that may raise significant safety risks when compounded [5].
Check what you know
Question 1 of 4
Score: 0 right, 0 of 4 answered
Frequently asked questions
What combination with sermorelin has been studied?
Does sermorelin affect fasting glucose?
Is sermorelin the same as growth hormone?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
What to avoid while taking sermorelin?
Very little is established about sermorelin drug interactions. The only combination described is intravenous sermorelin with arginine, used in adults as a diagnostic test. How sermorelin behaves alongside growth hormone, somatostatin analogues such as octreotide, glucocorticoids, sex hormones, opioids or diabetes drugs is not established.
How much sermorelin per day reddit?
The pediatric trial gave 30 micrograms/kg subcutaneously at bedtime, once nightly, for up to a year, in 110 previously untreated prepubertal children with growth hormone deficiency (86 evaluable). A short adult study used 0.5 mg and 1 mg subcutaneously twice daily for 14 days each, but it was not a clinical-benefit trial.
What should I take along with sermorelin?
No treatment pairing is established. The only combination described is intravenous sermorelin with arginine, a diagnostic test in adults, and it concerns diagnosis rather than the treatment or safety of the combination. Interactions with other medicines are not established.
References
Show all 7 referencesHide references
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
- Federal Register :: Request Access.
- Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
- Reddit participants. Thoughts on Sermorelin? (r/tirzepatidecompound). Accessed 2026-11-10.